The Trump administration’s dramatic reworking of U.S. public-health agencies’ approach to vaccines is creating a difficult and unpredictable situation for drugmakers.
Despite its massive $10.5 billion size and 12-drug scope, Pfizer’s oncology deal with Innovent Biologics took less than five months to forge, but not without undergoing some stress tests. The deal ...
Pfizer said on Thursday that finance chief Dave Denton will leave on August 15 to return to the consumer goods industry, after helping the U.S. drugmaker navigate its post-Covid transition. The ...
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today announced that Dave Denton, Chief Financial Officer, will step down from his current role and leave the company on August 15 for a professional ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results